Want to see TSE:NOVA full AI Analyst Report?
Top Page
Stuhini Exploration
(NOVA)
Select Model
Select Model
Rating:50Neutral
Price Target:
C$0.15
▼(-9.38% Downside)
Action:Reiterated
Date:01/24/26
The score is held down primarily by weak financial performance (no revenue, persistent losses, and ongoing cash burn), with valuation also constrained by negative earnings (negative P/E). These negatives are partially offset by favorable technicals (price above key moving averages with positive momentum) and a low-leverage balance sheet with no debt.
Positive Factors
Low financial leverage (no debt)
Zero reported debt reduces fixed obligations and lowers near-term solvency risk, giving management flexibility to prioritize exploration spending or partnerships without interest burdens. This durable capital structure helps sustain operations through extended exploration cycles.
Negative Factors
No revenue and recurring net losses
Absence of any reported revenue and persistent net losses (TTM net loss ~1.47M) mean the company lacks operating income to fund exploration or demonstrate commercial viability. This structural lack of revenue keeps the business dependent on external capital and raises execution risk for long‑term value creation.
Read all positive and negative factors
Positive Factors
Negative Factors
Low financial leverage (no debt)
Zero reported debt reduces fixed obligations and lowers near-term solvency risk, giving management flexibility to prioritize exploration spending or partnerships without interest burdens. This durable capital structure helps sustain operations through extended exploration cycles.
Read all positive factors
Stuhini Exploration (NOVA) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$10.04M
Dividend YieldN/A
Average Volume (3M)101.32K
Price to Earnings (P/E)―
Beta (1Y)1.04
Revenue GrowthN/A
EPS Growth48.22%
CountryCA
EmployeesN/A
SectorBasic Materials
Sector Strength58
IndustryIndustrial Materials
Share Statistics
EPS (TTM)-0.02
Shares Outstanding55,771,908
10 Day Avg. Volume81,233
30 Day Avg. Volume101,322
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)0.57
Price to Sales (P/S)0.00
P/FCF Ratio-6.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Stuhini Exploration Business Overview & Revenue Model
Company Description
Stuhini Exploration Ltd., a mineral exploration company, engages in the acquisition, exploration, and development of mineral properties. It explores for gold, silver, and base metal deposits. The company has option agreements to acquire 100% inter...
How the Company Makes Money
null...
Stuhini Exploration Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
34
Negative
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Stuhini Exploration Technical Analysis
Neutral
0.16
Price Trends
0.17
Positive
0.17
Positive
0.17
Positive
Market Momentum
<0.01
Positive
50.80
Neutral
22.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NOVA, the sentiment is Neutral. The current price of 0.16 is below the 20-day moving average (MA) of 0.18, below the 50-day MA of 0.17, and below the 200-day MA of 0.17, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 50.80 is Neutral, neither overbought nor oversold. The STOCH value of 22.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:NOVA.
Stuhini Exploration Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
50 Neutral | C$10.04M | -6.36 | -14.21% | ― | ― | 48.22% | |
47 Neutral | C$5.02M | -1.95 | -17.99% | ― | ― | 26.86% | |
45 Neutral | C$3.64M | -50.00 | -4.68% | ― | ― | 63.33% | |
39 Underperform | C$14.30M | -17.24 | -54.87% | ― | ― | 30.95% | |
31 Underperform | C$10.44M | -6.50 | -23.00% | ― | ― | 93.97% |
* Basic Materials Sector Average
TSE:NOVA
Stuhini Exploration
0.18
0.02
12.90%
TSE:MEK
Metals Creek Resources
0.05
0.03
150.00%
TSE:QMC
QMC Quantum Minerals
0.04
-0.02
-30.00%
TSE:HAR
Harfang Exploration
0.05
-0.03
-37.50%
TSE:GOH
GoldHaven Resources
0.22
0.08
65.38%
Stuhini Exploration Corporate Events
Business Operations and Strategy
Restart Life Leverages Certified Plant to Scale Functional Wellness Brands
Positive
Mar 11, 2026
Restart Life Sciences is highlighting the strategic value of its Holy Crap manufacturing facility, which holds multiple third-party certifications including organic, kosher, non-GMO, SQF, and regulatory approvals in Canada and the U.S. These crede...
Business Operations and Strategy
Restart Life Taps University of Manitoba to Bolster Science Behind Functional Foods
Positive
Mar 3, 2026
Restart Life Sciences has partnered with the University of Manitoba’s Richardson Centre for Food Technology and Research to support food-related scientific studies that will steer product development across its BrainQ, BrainBalls, Holy Crap,...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Restart Life Sciences Becomes Revenue Producer With Holy Crap Foods Acquisition
Positive
Feb 27, 2026
Restart Life Sciences has closed its acquisition of Holy Crap Foods Inc., securing 100% ownership of the functional cereal brand and its related assets, including intellectual property, inventory, and longstanding retail and distributor relationsh...
Business Operations and StrategyM&A Transactions
Restart Life Sciences to Acquire Holy Crap Foods in $1 Million Wellness Brand Deal
Positive
Feb 13, 2026
Restart Life Sciences Corp., a Canadian life sciences company, is expanding its footprint in health-focused consumer brands by acquiring Holy Crap Foods Inc., a premium breakfast cereal producer with a British Columbia-based manufacturing facility...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.